title: Rescue therapy for acute antibody mediated rejection with a proteosome inhibitor after kidney transplantation.
authors.affiliation: Department of Pharmacy, University of Maryland Medical Center, Baltimore, Maryland, USA.
authors.forename: Wana
authors.initials: W
authors.lastname: Manitpisitkul
authors.forename: Nikita S
authors.initials: NS
authors.lastname: Wilson
authors.forename: Benjamin
authors.initials: B
authors.lastname: Philosophe
authors.forename: Matthew
authors.initials: M
authors.lastname: Cooper
authors.forename: Cinthia
authors.initials: C
authors.lastname: Drachenberg
authors.forename: Debra
authors.initials: D
authors.lastname: Kukuruga
authors.forename: Joseph
authors.initials: J
authors.lastname: Nogueira
authors.forename: Abdolreza
authors.initials: A
authors.lastname: Haririan
mesh_terms: D000208:Acute Disease; D000328:Adult; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects*; D006680:HLA Antigens / Q000276:immunology*; D006801:Humans; D056724:Immunity, Humoral / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007518:Isoantibodies / Q000097:blood*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D011480:Protease Inhibitors / Q000627:therapeutic use*; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D061988:Proteasome Inhibitors; D011719:Pyrazines / Q000627:therapeutic use*; D016879:Salvage Therapy; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D001897:Boronic Acids; D006680:HLA Antigens; D007166:Immunosuppressive Agents; D007518:Isoantibodies; D011480:Protease Inhibitors; D061988:Proteasome Inhibitors; D011719:Pyrazines; D000069286:Bortezomib; D046988:Proteasome Endopeptidase Complex